PlainRecalls
FDA Devices Moderate Class II Ongoing

Lev5, REF CT1587B, 50 Susceptibility discs Levofloxacin 5 ug, IVD, CE 2797

Reported: February 12, 2025 Initiated: December 23, 2024 #Z-1075-2025

Product Description

Lev5, REF CT1587B, 50 Susceptibility discs Levofloxacin 5 ug, IVD, CE 2797

Reason for Recall

Mislabeling; Levofloxacin Antimicrobial susceptibility disc packaging may contain Norfloxacin Antimicrobial Susceptibility discs.

Details

Recalling Firm
Oxoid Limited
Units Affected
1406 units
Distribution
US: VA, CA, NE, MA, FL, CA, MA, NH, WA OUS: Austria, Australia, Brazil, Canada, China, Costa Rica, Germany, Spain, France, United Kingdom, Ghana, Hong Kong, South Korea, Netherlands, Peru, Philippines, Poland, Indonesia
Location
Basingstoke

Frequently Asked Questions

What product was recalled?
Lev5, REF CT1587B, 50 Susceptibility discs Levofloxacin 5 ug, IVD, CE 2797. Recalled by Oxoid Limited. Units affected: 1406 units.
Why was this product recalled?
Mislabeling; Levofloxacin Antimicrobial susceptibility disc packaging may contain Norfloxacin Antimicrobial Susceptibility discs.
Which agency issued this recall?
This recall was issued by the FDA Devices on February 12, 2025. Severity: Moderate. Recall number: Z-1075-2025.